Skip to content

Drug interactions

Brigatinib + Siponimod

Severity: Moderate

Brigatinib and Siponimod: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Brigatinib is a CYP3A4 inducer and may lower siponimod concentrations. The effect is greater in patients with reduced CYP2C9 activity, as CYP3A4 then plays a larger role in siponimod clearance, and it may reduce efficacy.

What this interaction means in plain words

Brigatinib and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Brigatinib belongs to Oncology; Siponimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

CYP3A4 induction increases siponimod metabolism and lowers its exposure.

What to do

Check CYP2C9 genotype, and avoid the combination in patients with CYP2C9*1/*3 or *2/*3 genotypes. Otherwise monitor for reduced siponimod efficacy and consider an alternative treatment.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Brigatinib and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Brigatinib with Siponimod?

MediHelp rates the interaction as moderate. Brigatinib and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Brigatinib is a CYP3A4 inducer and may lower siponimod concentrations. The effect is greater in patients with reduced CYP2C9 activity, as CYP3A4 then plays a larger role in siponimod clearance, and it may reduce efficacy.

How serious is the interaction between Brigatinib and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check CYP2C9 genotype, and avoid the combination in patients with CYP2C9*1/*3 or *2/*3 genotypes. Otherwise monitor for reduced siponimod efficacy and consider an alternative treatment.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in